Bill > SB83

This bill prohibits the Wisconsin Department of Health Services (DHS) from applying utilization management controls to FDA-approved antipsychotic prescription drugs under the Medical Assistance program. Utilization management controls are formal techniques used by health insurers or prescription drug management entities to evaluate the medical necessity, appropriateness, efficacy, and efficiency of prescription drugs, including prior authorization and step therapy protocols. The bill specifically creates a new section in the state statutes that defines prescription drugs (using the existing definition in section 450.01 (20)) and utilization management controls, and then explicitly prevents DHS from implementing any such controls on antipsychotic medications. This means that patients enrolled in the Medical Assistance program, which provides health services to individuals with limited financial resources, will have more direct access to prescribed antipsychotic medications without additional administrative barriers or requirements from the state health department.

Health and Social Services

https://docs.legis.wisconsin.gov/2025/proposals/reg/sen/bill/sb83